Breaking the Cycle: How One Hospital's Opioid Policy is Changing Lives
"Discover how a targeted approach to opioid prescriptions in emergency departments is leading to fewer visits and safer communities."
The opioid crisis in the United States has reached alarming levels, underscoring the urgent need for innovative strategies to curb opioid abuse and overdose. Emergency departments (EDs) often find themselves on the front lines, grappling with patients who frequently seek opioids for chronic pain. This revolving door phenomenon not only strains resources but also puts individuals at further risk.
In response to this challenge, one metropolitan hospital implemented a novel intervention: a "no superuser opioid prescription" policy. This initiative aimed to transition patients who frequently sought opioids in the ED to an outpatient chronic pain program. The goal was simple: to reduce the number of ED visits by these individuals and, in turn, decrease opioid prescriptions and related healthcare costs.
A recent study published in the Western Journal of Emergency Medicine has shed light on the effectiveness of this approach. Researchers analyzed the impact of the policy on superusers' annual ED visits, as well as its effects on statewide opioid prescriptions, unique prescribers, and ancillary testing. The results are promising and offer a potential blueprint for other hospitals grappling with similar challenges.
Emergency Care and Continuity
Emergency departments can be an appropriate setting for initiating opioid agonist treatment. Evidence indicates that starting buprenorphine in the ED can increase outpatient treatment linkage and decrease drug use compared with standard ED referral. Treatment with buprenorphine and methadone reduces morbidity and mortality for people with opioid use disorder. Sustaining treatment after an ED visit likely requires community-based follow-up and support, while high-quality evidence on ED-initiated interventions remains limited.
From Medicine to Crisis
Opioids have been used for centuries to manage or treat pain because they act on brain receptors involved in regulating pain and emotion. Natural opioids such as morphine come from the opium poppy, while synthetic opioids include methadone and fentanyl. The crisis is commonly dated to the 1990s, and research has examined the introduction and marketing of OxyContin as a potential leading cause of overdose deaths over the following two decades. Britannica describes the U.S. crisis as beginning in the late 1990s with the overprescription of painkillers.
How Does the 'No Superuser Opioid Prescription' Policy Work?
The “no-opioid” policy targeted patients identified as frequent ED visitors seeking opioids for chronic pain relief. The program's success hinged on a multi-faceted approach:
- Frequent use of the ED, defined as six or more visits per year.
- At least one visit identified by the attending physician as primarily driven by opioid-seeking behavior.
- Chart review by ED administration and case management for evidence of ED misuse.
What Current Studies Examine
Recent research has evaluated implemented care models and system changes in hospital emergency departments serving adults with mental illness, including outcomes, patient experience, and staff experience. A 2024 study reviewed buprenorphine prescribing and racial disparities among patients with opioid overdose using electronic medical records from an urban academic hospital in Alabama between January 1 and December 31, 2021. Systematic review work has also examined interventions for frequent ED-utilizing patients with chronic noncancer pain. Another 2024 study assessed whether a multipronged ED treatment program for acute opioid use disorder was associated with subsequent opioid overdose rates.
Limits of Policy Evidence
The evidence on a “No Superuser Opioid Prescription” policy comes from a retrospective observational analysis of a preexisting administrative database. The study was conducted at a large metropolitan hospital that belonged to a wide-reaching health system. Because the data were not prospectively collected, the findings have limitations for establishing cause and effect. The administrative protocol itself was performed in a prospective fashion, but that does not change the retrospective nature of the underlying analysis.
Comparing Emergency Responses
EMS and ED data can both provide near-real-time information about trends in nonfatal opioid-involved overdoses. However, the comparability of trends reported by these two data sources remains minimally studied. Opioid-involved overdoses, particularly those involving synthetic opioids such as fentanyl, have driven increases in overdose morbidity and mortality. Comparative research has also considered alternatives to opioids for acute ED pain, including intranasal ketamine versus intravenous opioids.
What Does This Mean for the Future of Opioid Management?
The study's findings suggest that targeted interventions, coupled with strong administrative support and EMR-based reminders, can significantly reduce ED visits and opioid prescriptions among superusers. By offering a pathway to chronic pain management and addiction treatment, hospitals can break the cycle of opioid dependence and improve patient outcomes. This approach not only benefits individuals but also eases the burden on emergency departments and contributes to safer communities.
Low-Threshold Treatment
The Assistant Secretary for Planning and Evaluation studied emergency department interventions for opioid use disorder through a literature review, expert interviews, and case studies of five ED programs. Emergency departments are positioned to reach people who have experienced an overdose or otherwise have limited interaction with the health care system. The CA Bridge model's key innovation is low-threshold buprenorphine initiation, encouraging EDs to offer buprenorphine during treatment-seeking visits, visits for complications of opioid use disorder, or after an overdose. These approaches frame the ED as an entry point into treatment rather than only a site for acute stabilization.
Better Data and Broader Tools
The CDC identifies monitoring trends, collecting and analyzing overdose data, and improving data quality as priorities for understanding and responding to the epidemic. A 2025 actuarial report lists drug-awareness campaigns, education, opioid settlement funds, syringe service programs, ED treatment initiation, and non-opioid pain treatment as additional responses. National DAWN data are being used to analyze trends in opioid-involved ED visits involving prescription opioids, fentanyl, heroin, and opioids not otherwise specified. The future of overdose and substance-related mortality remains uncertain, although recent decreases in mortality trends may reflect improvements in harm-reduction strategies.
An Entry Point to Care
Emergency departments can interact with people who have experienced an opioid overdose or have limited contact with the health care system, creating an opportunity to connect them with treatment. One documented case involved a 36-year-old man found unresponsive and cyanotic in a park after an unintentional opioid overdose; naloxone was administered and his mental status normalized. Case studies in opioid crisis response describe support that can include prevention education, intervention, treatment referrals, recovery coaching, and ongoing sobriety maintenance. Together, these examples show how emergency intervention can become a bridge to longer-term support.